We are using cookies to give you the best experience on our site. Cookies are files stored in your browser and are used by most websites to help personalise your web experience.
By continuing to use our website without changing the settings, you are agreeing to our use of cookies.

EuroELSO 2017

Thank you for your participation in the EuroELSO 2017 International Congress

LogoSmallEE2017

 CONGRESS PHOTOS:

camera icon

 

Current adult projects with our partner the International ECMO Network

LogoECMONet

     

      http://www.internationalecmonetwork.org

 

Position Paper for the Organization of Extracorporeal Membrane Oxygenation Programs for Acute Respiratory Failure in Adult Patients

American Journal of Respiratory and Critical Care Medicine
Online, July 2014

See full paper here

The aim of this paper is to provide physicians, ECMO center directors and coordinators, hospital directors, health care organizations, regional, national and international policy makers a description of the optimal approach to organizing ECMO programs for ARF in adult patients. Importantly, this will help ensure that ECMO is delivered safely and proficiently, such that future observational and randomized clinical trials assessing this technique may be performed by experienced centers under homogeneous and optimal conditions.

LIFEGARDS Study
ventiLatIon management oF patients with Extracorporeal membrane oxyGenation for Acute Respiratory Distress Syndrome

LIFEGARDS is a multicenter, observational study assessing the mechanical ventilation management of patients with ARDS undergoing ECMO, in a worldwide population over a one-year period.

HELP ECMO
HEparin Low-dose Protocol in ECMO Patients

HELP ECMO is a single center, randomized, controlled feasibility study assessing the use of low-dose heparin, as compared with full-dose heparin, in critically ill patients undergoing ECMO.

EOLIA
ECMO to rescue Lung Injury in severe ARDS

EOLIA is a multicenter, international, randomized, controlled trial run by the REVA network and endorsed by the International ECMO Network. The study hypothesizes that ECMO, instituted early after the diagnosis of very severe ARDS (P:F < 80), would lower the morbidity and mortality associated with this syndrome.

For further information please contact:

Susan Tanzi Pfeifer, MBA
Director of Operations
International ECMONet
Phone: 646-761-8691
Email: This email address is being protected from spambots. You need JavaScript enabled to view it. 

Sponsor

Getinge Logo
Eurosets Logo